Kent William Mouw

机构：Brigham and Women's Hospital, Harvard University, Massachusetts General Hospital, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center, Mass General Brigham · ORCID：0000-0001-7939-7343

发表论文 473 篇 · 总被引 7322 次 · h-index 39

代表论文

Bacillus Calmette-Guérin (BCG) and Beyond: Is Systemic Immunotherapy for BCG-Naïve Non–Muscle-Invasive Bladder Cancer Progress or Overreach? (2026 · Journal of Clinical Oncology · 被引 3)
Tumor-myeloid crosstalk drives therapy resistance in localized bladder cancer (2026 · Cell Press Blue · 被引 1)
Radiation and Avelumab in Cisplatin-Ineligible Patients With Muscle-Invasive Bladder Cancer (2026 · Clinical Genitourinary Cancer · 被引 1)
Supplementary Table S3 from A Phase II Study of Berzosertib in Combination with Carboplatin Compared with Docetaxel with Carboplatin in Metastatic Castration-Resistant Prostate Cancer (2026)
Figure 1 from A Phase II Study of Berzosertib in Combination with Carboplatin Compared with Docetaxel with Carboplatin in Metastatic Castration-Resistant Prostate Cancer (2026)
Table 1 from A Phase II Study of Berzosertib in Combination with Carboplatin Compared with Docetaxel with Carboplatin in Metastatic Castration-Resistant Prostate Cancer (2026)